CTOs on the Move

Harmac Medical Products

www.harmac.com

 
Harmac Medical Products, Inc is a Buffalo, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.harmac.com
  • 2201 Bailey Ave
    Buffalo, NY USA 14211
  • Phone: 716.897.4500

Executives

Name Title Contact Details

Similar Companies

Strata Skin Sciences

STRATA Skin Sciences is a medical technology company in dermatology dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions. Its products include the XTRAC® and now Pharos® excimer lasers and VTRAC® lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. The Company`s proprietary XTRAC and recently acquired Pharos excimer lasers deliver a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma, diseases which impact over 31 million patients in the United States alone. STRATA`s unique business model leverages targeted Direct to Consumer (DTC) advertising to generate awareness and utilizes its in-house call center and insurance advocacy teams to increase volume for the Company`s partner dermatology clinics.

Physicians Computer Company

Physicians Computer Company is a Winooski, VT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Neon Internet

Neon Internet, Inc. is a Carbondale, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CARE OPTICAL INDUSTRIAL CO

CARE OPTICAL INDUSTRIAL CO is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Trice Medical

Trice Medical was founded to fundamentally improve orthopedic diagnostics. Trice has pioneered fully integrated camera-enabled technologies that provide a clinical solution that is optimized for the physicians office. Our mission is to provide more immediate and definitive patient care, eliminating the false reads associated with current indirect modalities and significantly reduce the overall cost to the healthcare system.